Filter results
You can narrow down the results using the filters
Topics
Our work
Diseases
11455 results
-
COVID-19 vaccination – Geographic vaccination rates (LGA) – 29 September 2022
These reports list the percentage of people who have been vaccinated against COVID-19 by local government area (LGA). -
Commencement of new prescribed pattern of services – 30/20 telephone rule
Information on the new prescribed pattern of service 30/20 telephone rule, including relevant telephone attendance services. From 1 October 2022, GPs, Other Medical Practitioners and consultant physicians that claim relevant Medicare telephone items will be subject to the new rule. -
Digital Transformation Sector Partners meeting summary – 30 September 2022
This document summarises the discussion and outcomes of the first Digital Transformation Sector Partners meeting on 30 September 2022. -
Medical Research Future Fund 2nd 10-year Investment Plan (2022–23 to 2031–32)
The $6.3 billion MRFF 2nd 10-year Investment Plan outlines the Australian Government’s plans for the use of MRFF funding from 2022–23 to 2031–32. It updates and builds on the first 10-year Investment Plan. -
Vaccine safety in Australia AusVaxSafety – Summary report 2021
AusVaxSafety is a national system monitoring vaccine safety in Australia. The report shows how people receiving vaccines, or their parents and carers, responded to the SMS about their health a few days after vaccination at each schedule point in the National Immunisation Program in Australia 2021. -
AusVaxSafety COVID-19 vaccine surveillance – Summary report 2021
This report includes safety surveillance data collected by AusVaxSafety for all COVID-19 vaccine brands used in Australia from 22 February 2021 to 31 December 2021 and includes data pages specific to Aboriginal and Torres Strait Islander people. -
Strengthening Medicare Taskforce communique – 29 September 2022
This communique summarises the third meeting of the Strengthening Medicare Taskforce, held on 29 September 2022.
-
Australian Influenza Surveillance Reports – 2021
This collection contains fortnightly Australian Influenza Surveillance Reports (AISRs) from 2021. We publish these every fortnight during the influenza season, typically between May and October each year. -
Australian Influenza Surveillance Reports – 2020
This collection contains fortnightly Australian Influenza Surveillance Reports (AISRs) from 2022. We publish these every fortnight during the influenza season, typically between May and October each year. -
Australian Influenza Surveillance Reports – 2019
This collection contains fortnightly Australian Influenza Surveillance Reports (AISRs) from 2019. We publish these every fortnight during the influenza season, typically between May and October each year. -
Digital Transformation Sector Partners slide presentation – 2 September 2022
This presentation contains the slides presented at the first Digital Transformation Sector Partners meeting on 2 September 2022
-
Digital Transformation Sector Partners slide presentation – 16 September 2022
This presentation contains the slides presented at the first Digital Transformation Sector Partners meeting on 16 September 2022
-
National Notifiable Diseases Surveillance System (NNDSS) fortnightly reports – 5 September to 18 September 2022
This report, and accompanying table, provide a fortnightly summary on notifications of Australia's nationally notifiable diseases for 5 September to 18 September 2022. -
Digital Transformation Sector Partners slide presentation – 5 August 2022
This presentation contains the slides presented at the first Digital Transformation Sector Partners meeting on -
Residential Aged Care Provider process map
This map sets out the key process steps and system actions that Residential Aged Care Providers must complete to process a client for residential aged care funding. -
AISR fortnightly report no. 11 – 15 August to 28 August 2022
The fortnightly Australian Influenza Surveillance Report (AISR) includes information about influenza activity, severity, impact, at-risk populations, virology, and vaccine match and effectiveness. It also gives year-to-date data and comparisons. -
Aged Care Quality Standards – Public Consultation
We are currently reviewing the Aged Care Quality Standards. This fact sheet provides an overview of the review and the public consultation occurring from 17 October to 25 November 2022. -
Digital Transformation Sector Partners slide presentation – 19 August 2022
This presentation contains the slides presented at the first Digital Transformation Sector Partners meeting on 19 August 2022. -
Review of COVID-19 vaccine and treatment purchasing and procurement
This document contains the review of the purchasing and procurement of COVID-19 vaccine and treatments. -
Poster for the review of Aged Care Quality Standards
We are urgently reviewing the Aged Care Quality Standards and undertaking public consultation from 17 October to 25 November 2022. This poster is for providers and organisations to promote the public consultation. -
Advisory Committee for the COVID-19 Response for People with Disability – Summary of outcomes 13 September 2022
We provided updates on the COVID-19 vaccination rollout for people with disability and disability support workers. -
COVID-19 vaccination – Phase 2A of COVID-19 Vaccine Strategy – Privacy Impact Assessment report and Agency response
These documents contain a report of the Privacy Impact Assessment for the implementation of Phase 2A of the COVID-19 Vaccine Strategy and the Department of Health’s consolidated response. -
Reportable gifts received – September 2022
This report is of gifts given to officers of the Department of Health that are valued over $100, as at 3 September 2022. -
Biosimilar medicine fact sheet – follitropin alfa
This fact sheet provides information about biosimilar brands of follitropin alfa listed on the Pharmaceutical Benefits Scheme (PBS). -
Biosimilar medicine fact sheet – rituximab
This fact sheet provides information about biosimilar brands of rituximab listed on the Pharmaceutical Benefits Scheme (PBS).